Akero Therapeutics, Inc.

NASDAQ:AKRO

27.82 (USD) • At close December 31, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Omzet 0000.284000000000000000000000000
Kosten van de omzet 00.0010.0010.0020.0050.0690.0680.0650.0660.0650.0640.0630.060.060.0610000000000000
Brutowinst 0-0.001-0.0010.282-0.005-0.069-0.068-0.065-0.066-0.065-0.064-0.063-0.06-0.06-0.0610000000000000
Brutowinstmarge 0000.993000000000000000000000000
Onderzoek- en ontwikkelingskosten 72.23255.32250.6553.39238.63427.98521.78718.3225.08721.36320.51427.71119.4723.97610.60225.70917.37913.0378.79113.13813.8855.964.0631.9831.2538.420.2260.68
Algemene en administratieve kosten 9.47110.4199.3048.4817.9817.6446.9667.111.0046.2315.5374.7284.8834.994.5264.0744.1593.4173.5883.0832.4241.6491.4490.9850.4740.2420.1950.28
Verkoop- en marketingkosten 0-0.001-0.001-0.002000000000000000000000000
Verkoop-, algemene en administratieve kosten 9.47110.4189.3038.4797.9817.6446.9667.111.0046.2315.5374.7284.8834.994.5264.0744.1593.4173.5883.0832.4241.6491.4490.9850.4740.2420.1950.28
Overige kosten 0-10.4180-16.6267.8445.4033.3792.7230.8730.24400.0150.0230.0330.0380.0720.1350.2470.4930.610.7550.3810.15-58.504-9.421-0.01100
Bedrijfskosten 81.70365.7459.95361.87146.61535.62928.75325.4236.09127.59426.05132.43924.35328.96615.12829.78321.53816.45412.37916.22116.3097.6095.5122.9681.7278.6620.4210.96
Bedrijfsresultaat -81.703-65.741-59.954-61.873-46.615-35.629-28.753-25.42-36.091-27.594-26.051-32.439-24.353-28.966-15.128-29.783-21.538-16.454-12.379-16.221-16.309-7.609-5.512-2.968-1.727-8.662-0.421-0.96
Bedrijfsresultaat ratio 000-217.863000000000000000000000000
Totaal overige inkomsten en kosten netto 8.9989.7546.616.6876.9564.5462.9222.3610.5490.1910.0220.0150.0230.0330.0380.0720.1350.2470.4930.610.7550.3810.15-58.504-9.421-0.01100
Inkomen voor belasting -72.705-55.987-53.344-55.186-39.659-31.083-25.831-23.059-35.542-27.403-26.029-32.424-24.33-28.933-15.09-29.711-21.403-16.207-11.886-15.611-15.554-7.228-5.362-61.472-11.148-8.673-0.421-0.96
Inkomen voor belasting ratio 000-194.317000000000000000000000000
Belastingkosten 00-0.042-12.5278.7326.26-2.465-2.574-0.5490.297-0.022-0.011-0.051-0.05-0.05-0.011-0.006-1.323-1.237-0.046-16.309-7.609-5.362-2.9680-8.662-0.4210
Nettowinst -72.705-55.987-53.344-55.186-39.659-31.083-23.366-20.485-34.993-27.403-26.007-32.424-24.33-28.933-15.09-29.711-21.403-16.207-11.886-15.611-15.554-7.228-5.362-61.472-11.148-8.673-0.421-1.026
Nettowinstmarge 000-194.317000000000000000000000000
WPA (Winst Per Aandeel) -1.05-0.81-0.9-0.99-0.71-0.6-0.5-0.44-0.91-0.77-0.74-0.93-0.7-0.83-0.43-0.86-0.63-0.57-0.42-0.55-0.56-2.21-0.2-2.9-0.53-0.41-0.02-4.54
Verwaterde WPA -1.05-0.81-0.9-0.99-0.71-0.6-0.5-0.44-0.91-0.77-0.74-0.93-0.7-0.83-0.43-0.86-0.63-0.57-0.42-0.55-0.56-2.21-0.2-2.9-0.53-0.41-0.02-4.53
EBITDA -71.458-54.755-52.352-54.287-38.766-30.157-25.306-22.632-35.152-27.285-25.965-32.428-24.27-28.873-15.117-29.772-21.538-16.454-12.379-16.221-16.309-7.6090.15-2.968-11.148-0.081-0.421-0.066
EBITDA ratio 000-217.856000000000000000000000000